WHO’s Statement – 36 million people across the European Region may have developed long COVID over the first 3 years of the pandemic

Statement by Dr Hans Henri P. Kluge, WHO Regional Director for Europe to the press on COVID-19, extreme heat and mpox.

Statement – 36 million people across the European Region may have developed long COVID over the first 3 years of the pandemic (who.int)

Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations

Self-reported symptom studies rapidly increased understanding of SARS-CoV-2 during the COVID-19 pandemic and enabled monitoring of long-term effects of COVID-19 outside hospital settings. Post-COVID-19 condition presents as heterogeneous…

The Long Covid Sessions Podcast: New episode alert!

Are you looking for a good overview of all of the research into Long COVID? A Nature review paper undertaken by the Patient-Led Research Collaborative for Long COVID (PLRC)…

Systematic Review of the Prevalence of Long COVID

The authors of this publication conducted a systematic review to determine the prevalence of persistent symptoms, functional disability, or pathological changes in adults or children at least 12…

Long COVID has been characterized by T-cell dysregulation, inflammation, and an uncoordinated adaptive immune reaction to the SARS-CoV-2 virus – A cohort study

A recently published outstanding article authored by Dr. Kailin Yin, a postdoctoral fellow at Gladstone Institutes in Nadia Roan’s lab, is now available in Nature Immunology. In this…

Related Posts